Medtronic has been recognised as one of Australia and New Zealand’s most innovative companies.
The company was named on a prestigious annual list, published by The Australian Financial Review and Boss Magazine.
Medtronic was listed at number three on the Health Industry List, out of more than 800 nominated organisations across Australia and New Zealand.
The list is based on a rigorous assessment process managed by Australia’s leading innovation consultancy, Inventium, in conjunction with a panel of industry expert judges.
The assessment also measures a top innovation implemented in the past 12 months and the company was recognised for its MiniMed 670G system – an insulin pump with automatically delivers the precise amount of insulin, exactly when needed, for people living with Type 1 diabetes.
Medtronic Australasia vice-president and managing director, Tim Fortin, said the company was honoured to be recognised on the 2019 list.
“Since 1949, meaningful innovation has been etched into everything we do,” he said.
“This spirit of innovation is evidenced in our technologies, and the way we show up to work every day to improve community health outcomes.
“Globally, our therapies help more than two people every second, delivering on our mission to alleviate pain, restore health and extend life.”
Inventium also assesses internal elements such as innovation culture, strategy, resources and process, which demonstrate a sustainable and repeatable approach to innovation.
“At Medtronic, we believe patient-focused innovation – and strong partnerships – remain key to an even better, more impactful future,” Mr Fortin said.
“And that nurturing an innovation mindset supports our team to operate at the highest standards when challenging the status quo, to go beyond medical devices to deliver better outcomes to more patients efficiently," Mr Fortin said.
Medtronic is an APHA Major Sponsor.